Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.

NCT06528613 · clinicaltrials.gov ↗

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Benign Prostatic Hyperplasia

Sponsor

Elpen Pharmaceutical Co. Inc.